| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 65-75 kDa, reducing conditions. MW (theoretical): 49 kDa. The Recombinant Human CRACC/SLAMF7 Fc Chimera Protein from R&D Systems is derived from HEK293. The Recombinant Human CRACC/SLAMF7 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | 19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7, SLAMF7 |
|---|
| Gene, Accession, CAS # | Gene ID: 57823, Accession: Q9NQ25 |
|---|
| Catalog # | 1906-SF-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human CRACC/SLAMF7 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|